Document Detail


Clinical criteria and biochemical markers for the detection of systolic dysfunction.
MedLine Citation:
PMID:  10997744     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This study was designed to assess the use of clinical criteria and biochemical testing to detect systolic dysfunction. Our goal is to develop strategies that may enhance the detection and treatment of patients with early ventricular dysfunction while reducing the use of echocardiography. METHODS AND RESULTS: We compared the predictive characteristics of the plasma brain natriuretic peptide (BNP) concentration with that of a 5-point clinical score derived from elements of the history, electrocardiogram, and chest radiograph in outpatients (n = 466) referred for echocardiography because of symptoms of heart failure or risk factors for systolic dysfunction. Systolic dysfunction was defined as an ejection fraction (EF) less than 45% and was present in 10.9% of patients. By receiver operating characteristic analysis, BNP was sensitive and specific for the detection of systolic dysfunction, with an area under the receiver operating characteristic curve for the detection of EF less than 45% of 0.79. The BNP assay was abnormal in 41% of patients and identified a group with a high prevalence of systolic dysfunction (21% with an EF less than 45%), whereas a normal BNP value identified a group with a low prevalence of systolic dysfunction (4% with an EF less than 45%). The clinical score was positive in 43% of the population and identified a group with a high prevalence of systolic dysfunction (24% with an EF less than 45%). A normal score identified a group with a low prevalence of systolic dysfunction (1% with an EF less than 45%). CONCLUSION: This study supports previous studies, which showed that BNP assay predicts systolic dysfunction with acceptable sensitivity and specificity, and it underscores the effectiveness of additional readily available clinical criteria. Both of these strategies should be considered in screening for left ventricular dysfunction in populations at risk while limiting expensive cardiac imaging modalities.
Authors:
K Yamamoto; J C Burnett; E A Bermudez; M Jougasaki; K R Bailey; M M Redfield
Related Documents :
20067654 - Myocardial performance after successful intervention for native aortic coarctation.
11279304 - Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
20447804 - Correlation between plasma b-type natriuretic peptide levels and left ventricular diast...
15347604 - High concentrations of n-bnp are related to non-infectious severe sirs associated with ...
10963724 - Irfi 042, a novel dual vitamin e-like antioxidant, inhibits activation of nuclear facto...
8265744 - Psychosocial predictors of mortality in 83 women with premature acute myocardial infarc...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  6     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2001-01-09     Completed Date:  2001-01-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  194-200     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
Diagnosis, Differential
Echocardiography
Female
Heart Failure / etiology*
Humans
Male
Mass Screening / methods
Natriuretic Peptide, Brain / blood*
Predictive Value of Tests
ROC Curve
Risk
Sampling Studies
Severity of Illness Index
Stroke Volume
Systole
Ventricular Dysfunction, Left / diagnosis*,  physiopathology,  ultrasonography
Grant Support
ID/Acronym/Agency:
HL-033643/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Race-related differences among patients with left ventricular dysfunction: observations from a birac...
Next Document:  Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuret...